Prognostic Relevance of Metabolic Approach in Patients with Heart Failure

By  

Current Pharmaceutical Design, Vol. 15, Iss. 8, 2009-03 ,pp. : 883-892

Bentham Science Publishers

Access to resources Recommend Favorite

Candesartan plus spironolactone induces favourable left ventricular (LV) reverse remodeling in patients with mild to moderate chronic heart failure

By  

Inpharma, Vol. 1, Iss. 1601, 2007-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

Effects of Nebivolol versus Carvedilol on Left Ventricular Function in Patients with Chronic Heart Failure and Reduced Left Ventricular Systolic Function

By Lombardo Renzo M.R.  

American Journal of Cardiovascular Drugs, Vol. 6, Iss. 4, 2006-01 ,pp. : 259-263

Adis International

Access to resources Recommend Favorite

Long-term Pharmacological Activation of PPARγDoes not Prevent Left Ventricular Remodeling in Dogs with Advanced Heart Failure

By Suzuki George   Khanal Sanjaya   Rastogi Sharad   Morita Hideaki   Mishima Takayuki   Anagnostopoulos Petros   Nass Omar   Sharov Victor   Tanhehco Elaine   Goldstein Sidney   Sabbah Hani  

Cardiovascular Drugs and Therapy, Vol. 21, Iss. 1, 2007-02 ,pp. : 29-36

Springer Publishing Company

Access to resources Recommend Favorite

Metabolic Therapy of Heart Failure

By  

Current Pharmaceutical Design, Vol. 14, Iss. 25, 2008-09 ,pp. : 2582-2591

Bentham Science Publishers

Access to resources Recommend Favorite